| Dr Gary A Wasserman, MD | |
|
150 Tarrytown Rd, Manchester, NH 03103-2713 | |
| (603) 622-3162 | |
| (603) 622-8677 |
| Full Name | Dr Gary A Wasserman |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 150 Tarrytown Rd, Manchester, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104811595 | NPI | - | NPPES |
| 4201691 | Other | NH | AETNA NON-HMO |
| 30001529 | Medicaid | NH | |
| 0104466Y0NH01 | Other | NH | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 7291 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gary A Wasserman, MD 150 Tarrytown Road, Manchester, NH 03103-2713 Ph: (603) 622-3162 | Dr Gary A Wasserman, MD 150 Tarrytown Rd, Manchester, NH 03103-2713 Ph: (603) 622-3162 |
News Archive
Hapten Sciences, Inc., a privately held biotechnology company, announced today that it has filed an Investigational New Drug (IND) application and is now planning to initiate dosing of healthy volunteers in a first-in-human Phase 1 clinical trial of its lead product candidate, PDC-APB, a novel, first-in-class, compound in development for a new indication to prevent contact dermatitis due to exposure to poison ivy, oak, and sumac.
Could parental exposure to solvents at work be linked to autism spectrum disorder (ASD) in their children? According to an exploratory study by Erin McCanlies, a research epidemiologist from the National Institute for Occupational Safety and Health (NIOSH), and colleagues, such exposures could play a role, but more research would be needed to confirm an association.
Sanofi-aventis and BMP Sunstone Corporation announced today that they have entered into a definitive agreement under which sanofi-aventis is to acquire all outstanding shares of BMP Sunstone for cash consideration of USD 10 per share, or a total of approximately USD 520.6 million on a fully diluted basis.
Protalix BioTherapeutics, Inc., announced today it has submitted validation data regarding the Company's manufacturing process for taliglucerase alfa to the U.S. Food and Drug Administration (FDA). The Company made the submission in response to a request from the FDA for validation data from the Company's upgraded manufacturing facility. The FDA is currently reviewing the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease.
› Verified 5 days ago
Dr. Mary Jo Montanarella, M.D Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 30 Canton St, Suite 6, Manchester, NH 03103 Phone: 603-624-1638 Fax: 603-624-1972 | |
Damian Olsen, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 88 Mcgregor St Ste 201, Manchester, NH 03102 Phone: 603-314-7595 | |
Dr. Shirley V Galucki, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 Hitchcock Way, Manchester, NH 03104 Phone: 603-695-2500 | |
Melissa Culverwell, ARNP Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 150 Tarrytown Rd, Manchester, NH 03103 Phone: 603-622-3162 Fax: 603-622-8677 | |
Dr. Erron Laskin Kinsler, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 100 Hitchcock Way, Manchester, NH 03104 Phone: 603-695-2900 Fax: 603-695-2919 | |
Dr. Jennifer M. Donofrio, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 150 Tarrytown Rd, Manchester, NH 03103 Phone: 603-622-3162 Fax: 603-622-8677 |